0001192482-18-000180.txt : 20180508
0001192482-18-000180.hdr.sgml : 20180508
20180508172144
ACCESSION NUMBER: 0001192482-18-000180
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180504
FILED AS OF DATE: 20180508
DATE AS OF CHANGE: 20180508
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Berelowitz Michael
CENTRAL INDEX KEY: 0001493383
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36329
FILM NUMBER: 18815848
MAIL ADDRESS:
STREET 1: 415 EAST 37TH STREET
STREET 2: APT 36C
CITY: NEW YORK
STATE: NY
ZIP: 10016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Recro Pharma, Inc.
CENTRAL INDEX KEY: 0001588972
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261523233
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: (484) 395-2400
MAIL ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2018-05-04
0001588972
Recro Pharma, Inc.
REPH
0001493383
Berelowitz Michael
C/O RECRO PHARMA, INC.
490 LAPP ROAD
MALVERN
PA
19355
1
0
0
0
Common Stock
2018-05-04
4
A
0
6183
0
A
6183
D
Stock Option (right to buy)
11.32
2018-05-04
4
A
0
5742
0
A
2028-05-04
Common Stock
5742
5742
D
All shares of common stock are represented by unvested restricted stock units that will vest on May 4, 2019. Vested shares will be delivered to the reporting person within 30 days following the vesting date.
The stock option will vest on May 4, 2019.
/s/ Ryan Lake, Attorney-in-fact
2018-05-08